Loading…

Estimation versus measurement of the glomerular filtration rate for kidney function assessment in patients with cancer undergoing cisplatin-based chemotherapy

Glomerular filtration rate (GFR) assessment is indicated before every administration of cisplatin. The optimal modality for this purpose [GFR measurement by urinary Creatinine Clearance (uCrCl) versus GFR estimation (eGFR) by the CKD-EPI formula versus both] is unclear. We investigated whether eGFR...

Full description

Saved in:
Bibliographic Details
Published in:Scientific reports 2020-07, Vol.10 (1), p.11219, Article 11219
Main Authors: Klöckl, Marie-Christin, Kasparek, Anne-Katrin, Riedl, Jakob M., Moik, Florian, Mollnar, Stefanie, Stotz, Michael, Szkandera, Joanna, Terbuch, Angelika, Gerger, Armin, Niedrist, Tobias, Pichler, Martin, Bauernhofer, Thomas, Schilcher, Gernot, Zitta, Sabine, Rosenkranz, Alexander R., Friedl, Claudia, Stöger, Herbert, Posch, Florian
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Glomerular filtration rate (GFR) assessment is indicated before every administration of cisplatin. The optimal modality for this purpose [GFR measurement by urinary Creatinine Clearance (uCrCl) versus GFR estimation (eGFR) by the CKD-EPI formula versus both] is unclear. We investigated whether eGFR only is safe in this setting. Paired uCrCl and eGFR determinations from 470 cisplatin cycles from 121 patients were analyzed [median age: 55 years; most frequent tumor site: genitourinary (45%); palliative treatment: n = 41 (34%)]. Primary endpoint was the proportion of cycles with uCrCl 
ISSN:2045-2322
2045-2322
DOI:10.1038/s41598-020-68010-5